K1S
N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
Find entries where: K1S
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
Identifiers | ~{N},~{N}-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
Formula | C10 H15 N5 |
Molecular Weight | 205.26 |
Type | NON-POLYMER |
Isomeric SMILES | CCN(CC)c1cc(nc2n1ncn2)C |
InChI | InChI=1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-10-11-7-12-15(9)10/h6-7H,4-5H2,1-3H3 |
InChIKey | GSNOZLZNQMLSKJ-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 30 |
Chiral Atom Count | 0 |
Bond Count | 31 |
Aromatic Bond Count | 10 |
Drug Info: DrugBank
DrugBank ID | DB09283 |
---|---|
Name | Trapidil |
Groups | experimental |
Description | Trapidil, a platelet-derived growth factor antagonist, was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease. |
Synonyms | Trapidil |
Indication | Used in the treatment of chronic stable angina [A19770]. |
Categories |
|
ATC-Code | C01DX11 |
CAS number | 15421-84-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Cyclic nucleotide phosphodiesterase | MGSSATEIEELENTTFKYLTGEQTEKMWQRLKGILRCLVKQLERGDVNVV... | unknown | inhibitor |
Platelet-derived growth factor receptor beta | MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTF... | unknown | antagonist |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 5531 |
ChEMBL | CHEMBL132767 |
ChEBI | CHEBI:32254 |